Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
(2r,3r)-n^1^-[(1s)-2,2-dimethyl-1-(methylcarbamoyl)propyl]-n^4^-hydroxy-2-(2-methylpropyl)-3-{[(1,3-thiazol-2-ylcarbonyl)amino]methyl}butanediamide
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
This drug is a small molecule experimental compound with the molecular formula C20H33N5O5S and a molecular weight of approximately 455.6 g/mol[1][6]. It belongs to the class of n-acyl-alpha amino acids and derivatives[6]. The mechanism of action is not explicitly described in available sources; however, its structure suggests potential activity as an enzyme inhibitor or modulator due to the presence of thiazole and hydroxamic acid moieties. There is no publicly available information on primary indication or clinical development status for this specific compound.
- Other names
- (2R,3R)-N^1^-((1S)-2,2-Dimethyl-1-(methylcarbamoyl)propyl)-N^4^-hydroxy-2-(2-methylpropyl)-3-(((1,3-thiazol-2-ylcarbonyl)amino)methyl)butanediamide(2R,3R)-N^1^-[(1S)-2, 22-DIMETHYL- 11-(METHYLCARBAMOYL)PROPYL]- N^4^-HYDROXY -22-(22-METHYLPROPYL ) -33 -{ [(11 ,33-THIAZOL -22-YLCARBONYL ) AMINO ] METHYL } BUTANEDIAMIDE(WR compound)WR compound
Beyond the preview
Go deeper on (2r,3r)-n^1^-[(1s)-2,2-dimethyl-1-(methylcarbamoyl)propyl]-n^4^-hydroxy-2-(2-methylpropyl)-3-{[(1,3-thiazol-2-ylcarbonyl)amino]methyl}butanediamide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on (2r,3r)-n^1^-[(1s)-2,2-dimethyl-1-(methylcarbamoyl)propyl]-n^4^-hydroxy-2-(2-methylpropyl)-3-{[(1,3-thiazol-2-ylcarbonyl)amino]methyl}butanediamide.